Routinely Collected Clinical Data and Evaluation of Antimicrobial Target Attainment

NCT06427317 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 323

Last updated 2024-05-23

No results posted yet for this study

Summary

The primary aim of the study is to determine the proportion of individuals receiving beta-lactam antibiotics at Imperial College Healthcare NHS Trust in whom drug concentration targets are achieved.

Conditions

  • Infections, Bacterial
  • Pharmacokinetics
  • Drug Monitoring
  • Drug-Related Side Effects and Adverse Reactions

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Alison Holmes, MD · Imperial College London

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-19
Primary Completion
2027-03-19
Completion
2027-03-19

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06427317 on ClinicalTrials.gov